title: Imatinib does not inhibit neutrophil oxidative burst function in patients with chronic myelogenous leukemia.
authors.forename: P
authors.initials: P
authors.lastname: Bizargity
authors.forename: C
authors.initials: C
authors.lastname: Adigüzel
authors.forename: G
authors.initials: G
authors.lastname: Ozilhan
authors.forename: M
authors.initials: M
authors.lastname: Bayik
authors.forename: E
authors.initials: E
authors.lastname: Eksioglu-Demiralp
mesh_terms: D001549:Benzamides; D005434:Flow Cytometry; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000097:blood / Q000188:drug therapy*; D009504:Neutrophils / Q000187:drug effects* / Q000378:metabolism*; D010101:Oxygen Consumption / Q000187:drug effects; D010879:Piperazines / Q000494:pharmacology*; D011743:Pyrimidines / Q000494:pharmacology*; D016897:Respiratory Burst / Q000187:drug effects*
chemical_list: D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate